Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -161,381 | -161,867 | -103,227 | -64,873 | -23,973 |
| Depreciation Amortization | 2,405 | 2,068 | 286 | 28 | 22 |
| Income taxes - deferred | 4,361 | -3,156 | -978 | -197 | -46 |
| Accounts payable and accrued liabilities | -4,969 | -4,705 | 8,823 | 1,006 | 119 |
| Other Working Capital | -4,315 | -17,351 | 18,328 | 13,926 | 1,762 |
| Other Operating Activity | 27,367 | 26,642 | -4,244 | -109 | 249 |
| Operating Cash Flow | $-136,532 | $-158,369 | $-81,012 | $-50,219 | $-21,867 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,161 | 52,417 | -233,908 | N/A | N/A |
| PPE Investments | -283 | -3,203 | -5,290 | -69 | -3 |
| Investing Cash Flow | $-23,444 | $49,214 | $-239,198 | $-69 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 228,222 | 84,225 | 159,571 | N/A | 10 |
| Other Financing Activity | -1,136 | -118 | 187,165 | 39,873 | 42,499 |
| Financing Cash Flow | $227,086 | $84,107 | $346,736 | $39,873 | $42,509 |
| Beginning Cash Position | 47,138 | 72,186 | 45,660 | 56,075 | 35,436 |
| End Cash Position | 114,248 | 47,138 | 72,186 | 45,660 | 56,075 |
| Net Cash Flow | $67,110 | $-25,048 | $26,526 | $-10,415 | $20,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -136,532 | -158,369 | -81,012 | -50,219 | -21,867 |
| Capital Expenditure | -283 | -3,203 | -5,290 | -69 | -3 |
| Free Cash Flow | -136,815 | -161,572 | -86,302 | -50,288 | -21,870 |